5 | Analgesics (Analgesic Drugs)IBA
01/2017
-
03/2004 |
3 | Proteins (Proteins, Gene)FDA Link
07/2019
-
01/2014 |
3 | Platelet Activating FactorIBA
01/2017
-
01/2014 |
2 | Pharmaceutical PreparationsIBA
07/2019
-
11/2016 |
2 | GhrelinIBA
01/2017
-
01/2017 |
2 | 1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA
01/2017
-
01/2014 |
2 | liu-jun-zi-tangIBA
01/2017
-
02/2014 |
2 | EnzymesIBA
01/2017
-
01/2014 |
2 | Morphine (MS Contin)FDA LinkGeneric
10/2014
-
01/2014 |
2 | Small Interfering RNA (siRNA)IBA
10/2014
-
01/2014 |
2 | Opioid Analgesics (Opioids)IBA
10/2014
-
01/2014 |
2 | Lidocaine (Xylocaine)FDA LinkGeneric
02/2012
-
02/2012 |
2 | OrexinsIBA
05/2005
-
03/2004 |
2 | Ribavirin (Virazole)FDA LinkGeneric
10/2003
-
07/2003 |
1 | Myelin Basic ProteinIBA
01/2022 |
1 | Sodium Channels (Sodium Channel)IBA
04/2020 |
1 | taxaneIBA
04/2020 |
1 | A Kinase Anchor ProteinsIBA
07/2019 |
1 | 2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
07/2019 |
1 | Carboplatin (JM8)FDA LinkGeneric
07/2019 |
1 | 2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
07/2019 |
1 | Pattern Recognition ReceptorsIBA
01/2019 |
1 | Histocompatibility Antigens Class IIBA
01/2019 |
1 | lysophosphatidic acidIBA
01/2017 |
1 | ABT 491IBA
01/2017 |
1 | des-n-octanoyl ghrelinIBA
01/2017 |
1 | Adenosine Triphosphate (ATP)IBA
01/2017 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 |
1 | Free RadicalsIBA
01/2017 |
1 | Hormones (Hormone)IBA
01/2017 |
1 | AnthracyclinesIBA
01/2017 |
1 | Glutamic Acid (Glutamate)FDA Link
11/2016 |
1 | SaltsIBA
11/2016 |
1 | Amino AcidsFDA Link
11/2016 |
1 | Arginine (L-Arginine)FDA Link
11/2016 |
1 | Olanzapine (Zyprexa)FDA Link
08/2016 |
1 | Antipsychotic Agents (Antipsychotics)IBA
08/2016 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
08/2016 |
1 | Capsaicin (Zostrix)FDA Link
02/2016 |
1 | TRPV Cation ChannelsIBA
02/2016 |
1 | Tramadol (K315)FDA LinkGeneric
04/2015 |
1 | ALX 1393IBA
10/2014 |
1 | N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA
10/2014 |
1 | Glycine Plasma Membrane Transport ProteinsIBA
10/2014 |
1 | DNA Transposable Elements (Element, IS)IBA
10/2014 |
1 | StrychnineIBA
10/2014 |
1 | Serum AlbuminIBA
02/2014 |
1 | platelet activating factor receptorIBA
01/2014 |
1 | WEB 2086 (apafant)IBA
01/2014 |
1 | TCV 309IBA
01/2014 |
1 | BN 50739IBA
01/2014 |
1 | Formaldehyde (Formol)FDA Link
09/2013 |
1 | AdrenomedullinIBA
09/2013 |
1 | Nerve Growth Factor (NGF)IBA
02/2012 |
1 | Substance PIBA
12/2010 |
1 | F-Box ProteinsIBA
09/2009 |
1 | MyogeninIBA
09/2009 |
1 | Dexamethasone (Maxidex)FDA LinkGeneric
09/2009 |
1 | Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2007 |
1 | ProstaglandinsIBA
01/2007 |
1 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2007 |
1 | SC 560IBA
01/2007 |
1 | Streptozocin (Streptozotocin)FDA Link
01/2007 |
1 | 1- ((4- methylsulfonyl)phenyl)- 3- trifluoromethyl- 5- (4- fluorophenyl)pyrazoleIBA
01/2007 |